Regenxbio (RGNX) Asset Writedowns and Impairment (2024)
Regenxbio (RGNX) recorded quarterly Asset Writedowns and Impairment of $700000.0 in Q1 2024.
Regenxbio (RGNX) Asset Writedowns and Impairment (2024) Analysis & Trends
Regenxbio's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $700000.0 for Q1 2024.
- In Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $700000.0; the TTM figure through Dec 2024 stood at $700000.0 (changed N/A YoY), while the FY2024 annual figure was $2.1 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $700000.0 for Q1 2024 at Regenxbio.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $700000.0 in Q1 2024 to a low of $700000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Regenxbio | 325.94 Mn | 95.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |